microRNA Profile in Umbilical Cord Blood NK Cells

NCT ID: NCT00751569

Last Updated: 2008-09-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

5 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-09-30

Study Completion Date

2009-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Umbilical cords contain immature blood cells, including a group of lymphocytes, that are important in the so-called natural immunity. We want to study the cytokine levels in umbilical cord NK cells and its regulation a family of newly identified small RNAs (microRNAs).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Our preliminary data pointed to the possibility of cytokine regulation by microRNAs in NK lymphoma and NK lymphoma cell lines. We want to use umbilical cord blood as controls for the biological significance in normal NK cell development.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pregnant Women

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

umbilical cord blood

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

A1

A group of 3 to 5 pregnant women as donors for umbilical cord blood

blood donation

Intervention Type OTHER

obtaining cord blood

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

blood donation

obtaining cord blood

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

cord blood donation

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Normal pregnant women

Exclusion Criteria

* None
Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Taiwan University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

national Taiwan University Hospital

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Chung-Wu Lin

Role: PRINCIPAL_INVESTIGATOR

National Taiwan University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

National Taiwan University Hospital

Taipei, , Taiwan

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Taiwan

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Chung-wu LIn

Role: CONTACT

Phone: 02-23123456

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Chung-Wu Lin

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

200808006R

Identifier Type: -

Identifier Source: org_study_id